Arterys Cardio DL vs Imbio RV/LV Software

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Arterys (now part of Tempus)
VS
by Imbio

AI Verdict

Tool A, Arterys Cardio DL, focuses on comprehensive cardiac MRI analysis, offering automated ventricle segmentations and advanced flow quantification. In contrast, Tool B, Imbio RV/LV Software, specializes in analyzing CTPA scans to automatically measure right and left ventricular diameters and calculate their ratio, primarily for risk stratification in pulmonary conditions. While both leverage AI for cardiac imaging, their distinct input modalities and specific analytical outputs make them suitable for different clinical contexts and workflows.

Choose Arterys Cardio DL if…

Choose Arterys Cardio DL if your primary need is a comprehensive, AI-powered solution for cardiac MRI analysis that significantly reduces manual interpretation time. This tool is ideal for clinics and hospitals requiring automated, editable ventricle segmentations, 4D Flow post-processing for blood flow visualization, and quantitative delayed enhancement analysis to enhance diagnostic accuracy for a wide range of cardiac conditions.

View Arterys Cardio DL →

Choose Imbio RV/LV Software if…

Choose Imbio RV/LV Software if you require a fully automated, AI-driven solution for quickly assessing right and left ventricular diameters from CTPA scans. This tool is best suited for emergency departments or critical care settings where rapid calculation of the RV/LV ratio is essential for risk stratification in patients with suspected pulmonary conditions, such as pulmonary embolism.

View Imbio RV/LV Software →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Arterys Cardio DL Imbio RV/LV Software
Pricing Unknown Subscription-based
Deployment Cloud-based (SaaS), integrates with existing PACS or EHR, web-based zero-footprint viewer (Mac, PC, tablet, phone). [4, 7, 9, 13, 27] Cloud-based (Imbio Cloud in AWS with Imbio Bridge), on-premise (Imbio Enterprise as a software-only VMware solution), or via partner platforms (e.g., Nuance, Aidoc, Siemens Syngo.via, TeraRecon, FerrumHealth, Flywheel).
FDA Status 1 AI-estimated Yes AI-estimated
HIPAA Yes AI-estimated Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Arterys Cardio DL

Arterys Cardio DL's emphasis on 'editable automated contours' provides a crucial level of user control and clinical confidence, allowing for refinement of AI-generated results. While Imbio offers a fully automated workflow, the explicit mention of editability in Arterys suggests a more flexible and clinically adaptable user experience.

Clinical Value

Arterys Cardio DL

Arterys Cardio DL offers a broader and more in-depth range of advanced cardiac MRI analyses, including 4D Flow post-processing and Quantitative Delayed Enhancement analysis, which provide comprehensive diagnostic insights into complex cardiac conditions. While Imbio provides a critical risk stratification metric for pulmonary embolism, Arterys' features appear to offer deeper and more varied clinical utility.

Pricing & Value

Imbio RV/LV Software

Imbio provides a transparent pricing model, clearly stating it is subscription-based and dependent on the number of analyses or installations. This upfront clarity allows potential customers to better understand the cost structure without initial engagement, unlike Arterys which requires direct contact for pricing.

Enterprise Readiness

Imbio RV/LV Software

Imbio demonstrates superior enterprise readiness through its extensive deployment flexibility, offering cloud, on-premise, and integration via numerous partner platforms. This wide range of options, coupled with explicit DICOM compliance and PACS integration, allows it to adapt more seamlessly to diverse healthcare IT infrastructures.

Innovation

Arterys Cardio DL

Arterys Cardio DL showcases more groundbreaking innovation by claiming to be 'The world's first internet platform for medical imaging' and incorporating advanced techniques like 4D Flow post-processing and Quantitative Delayed Enhancement analysis. These features represent significant advancements in comprehensive cardiac MRI analysis beyond automated measurements.

Support & Docs

Imbio RV/LV Software

Imbio offers a more robust and transparent support infrastructure, including a dedicated support page with specified hours, multiple contact options (phone, email, online form), and clear indications for accessing user manuals and product documentation. This level of detail and accessibility surpasses what is readily available for Arterys.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Arterys Cardio DL Imbio RV/LV Software
Name Arterys Cardio DL Imbio RV/LV Software
Description FDA-cleared, cloud-based AI software that provides automated, editable ventricle segmentations for cardiac MRI analysis, drastically reducing interpretation time and enhancing diagnostic accuracy. AI-powered tool that automatically measures right and left ventricular diameters from CTPA scans, providing a ratio to aid in risk stratification for pulmonary conditions like pulmonary embolism.
Company ARTERYS Imbio
Categories Cardiology AI, Radiology & Imaging AI Cardiology AI, Radiology & Imaging AI
Specialties Cardiology, Radiology Cardiology, Pulmonology, Radiology
Key Features Automated ventricle segmentations for cardiac MRI; Deep learning algorithms for image analysis; Cloud-based platform for accessibility and performance; Vendor-agnostic compatibility; Rapid analysis (seconds vs. 30-60 minutes); Editable automated contours; 4D Flow post-processing for blood flow visualization and quantification; Quantitative Delayed Enhancement analysis Automated measurement of right and left ventricular diameters; Calculation and reporting of RV/LV ratio; Artificial intelligence algorithm for ventricle identification and measurement; Provides annotated images showing ventricular measurements; Generates summary PDF reports; Fully automated workflow, no user intervention required after scan completion; DICOM compliant input and output; Integration with standard reading environments (PACS)

Videos

Demos, reviews, and walkthroughs featuring Arterys Cardio DL and Imbio RV/LV Software.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Arterys Cardio DL is designed for cardiac MRI analysis, providing automated, editable ventricle segmentations, 4D Flow post-processing, and Quantitative Delayed Enhancement analysis. In contrast, Imbio RV/LV Software processes CTPA scans to automatically measure right and left ventricular diameters and calculate their ratio, primarily for risk stratification in pulmonary conditions like pulmonary embolism.
Arterys Cardio DL provides automated ventricle segmentations that are editable, allowing physicians to review and modify the contours. Imbio RV/LV Software features a fully automated workflow, requiring no user intervention after scan completion, and generates summary PDF reports and annotated images showing ventricular measurements.
Arterys Cardio DL includes advanced features such as 4D Flow post-processing for blood flow visualization and quantification, and Quantitative Delayed Enhancement analysis. Imbio RV/LV Software's primary advanced feature is the automated calculation and reporting of the RV/LV ratio from CTPA scans, which is a key patient risk indicator for pulmonary embolism.
AI Tool Finder
AI-powered search. Results may not be comprehensive.